Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM
Clinical trial NCT06447727 · UNKNOWN
Trial details
- NCT number
- NCT06447727
- Sponsor
- Zhongda Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-20
- Primary completion
- 2025-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.